Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Saskatchewan

$17,500.00

Total Metabolome Normalization in Urine Biomarker Research to Distinguish Between Respiratory Illnesses: COPD and Asthma

FY 2023-24

Summary
Asthma and Chronic Obstructive Pulmonary Disease are respiratory diseases, which are a leading cause of healthcare cost and even death. Treatment of respiratory illnesses is dependent on effective diagnosis, but this is more difficult with respiratory disease. Family doctors, who see the majority of disease, are not able measure airway inflammation in clinic. A better test could improve diagnosis without requiring a specialist. The metabolome is the collection of metabolites created in the body. Disease states change the metabolome. The analysis of individual metabolomes as a method of monitoring disease states is a step towards personalized medicine. Urine is a simple and non-invasive way to collect information about patients which can be used to analyze the metabolome and determine biomarkers for disease. Urine metabolomics requires a method of normalization to account for the hydration status of the patient at the time of collection. Creatinine is traditionally used to normalize but is not effective if a person has kidney dysfunction. In addition, we have concerns of the accuracy of creatinine based on results of our previous studies. It is affected by age or higher body mass index (BMI). Total metabolome is a novel method of normalization. This project seeks to develop this novel method as an alternative to creatinine for its ability to distinguish between respiratory disease states. We already have the LC-MS-MS methods to quantify 43 potential biomarkers for COPD and asthma. Further sample analysis is required to confirm the diagnostic viability of the biomarkers based on their normalization for hydration using the total metabolome. The total metabolome method is expected to study a wider range of people without the concerns of variable creatinine.
Program
Master's Award: Canada Graduate Scholarships
Location
Saskatchewan, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506036
Name
Finch Emma L
Region
Saskatchewan
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Total Metabolome Normalization in Urine Biomarker Research to Distinguish Between Respiratory Illnesses: COPD and Asthma
Programtype2
Studentship Programs
Orgnameinp2
University of Saskatchewan
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Analytical Chemistry; Asthma; Biomarkers; Chronic Obstructive Pulmonary Disease; Mass Spectrometry; Metabolomics; Normalization; Respiratory Disease; Urine; Validation
Abstract
Asthma and Chronic Obstructive Pulmonary Disease are respiratory diseases, which are a leading cause of healthcare cost and even death. Treatment of respiratory illnesses is dependent on effective diagnosis, but this is more difficult with respiratory disease. Family doctors, who see the majority of disease, are not able measure airway inflammation in clinic. A better test could improve diagnosis without requiring a specialist. The metabolome is the collection of metabolites created in the body. Disease states change the metabolome. The analysis of individual metabolomes as a method of monitoring disease states is a step towards personalized medicine. Urine is a simple and non-invasive way to collect information about patients which can be used to analyze the metabolome and determine biomarkers for disease. Urine metabolomics requires a method of normalization to account for the hydration status of the patient at the time of collection. Creatinine is traditionally used to normalize but is not effective if a person has kidney dysfunction. In addition, we have concerns of the accuracy of creatinine based on results of our previous studies. It is affected by age or higher body mass index (BMI). Total metabolome is a novel method of normalization. This project seeks to develop this novel method as an alternative to creatinine for its ability to distinguish between respiratory disease states. We already have the LC-MS-MS methods to quantify 43 potential biomarkers for COPD and asthma. Further sample analysis is required to confirm the diagnostic viability of the biomarkers based on their normalization for hydration using the total metabolome. The total metabolome method is expected to study a wider range of people without the concerns of variable creatinine.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Finch, Emma L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~
University of Saskatchewan - $17,500 Grant (2023-24) | Canada Spends